Published in Endocr Rev on June 01, 1995
Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients | NCT00369798
A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell. Proc Natl Acad Sci U S A (2001) 2.36
A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway. Proc Natl Acad Sci U S A (1997) 1.95
The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579. EMBO J (1999) 1.85
In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors. J Gen Physiol (2001) 1.78
Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice. Proc Natl Acad Sci U S A (1999) 1.73
Phosphodiesterase 4D is required for beta2 adrenoceptor subtype-specific signaling in cardiac myocytes. Proc Natl Acad Sci U S A (2005) 1.65
Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochem J (1997) 1.51
Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells. J Cell Biol (1998) 1.50
Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. Proc Natl Acad Sci U S A (2000) 1.47
cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model. Biochem J (1998) 1.46
Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue. Biochem J (2005) 1.43
The PDE1-encoded low-affinity phosphodiesterase in the yeast Saccharomyces cerevisiae has a specific function in controlling agonist-induced cAMP signaling. Mol Biol Cell (1999) 1.37
Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies. Biochem J (2006) 1.31
Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response. Proc Natl Acad Sci U S A (2006) 1.23
cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes. J Clin Invest (1997) 1.23
Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodents. J Clin Invest (1998) 1.20
The protein kinase A pathway-regulated transcriptome of endometrial stromal fibroblasts reveals compromised differentiation and persistent proliferative potential in endometriosis. Endocrinology (2010) 1.15
Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation. Biochem J (1998) 1.11
Compartmentation of cAMP signaling in cardiac myocytes: a computational study. Biophys J (2007) 1.07
Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3. Biochem J (1997) 1.04
The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways. Br J Pharmacol (2000) 0.95
Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts. J Biol Chem (2008) 0.95
Identification and characterization of the human homologue of the short PDE4A cAMP-specific phosphodiesterase RD1 (PDE4A1) by analysis of the human HSPDE4A gene locus located at chromosome 19p13.2. Biochem J (1998) 0.94
Identification of a novel isoform of the cyclic-nucleotide phosphodiesterase PDE3A expressed in vascular smooth-muscle myocytes. Biochem J (2001) 0.91
Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes. Proc Natl Acad Sci U S A (1998) 0.91
Evaluation of the phosphodiesterase 3 inhibitor ORG 9935 as a contraceptive in female macaques: initial trials. Contraception (2009) 0.89
Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br J Pharmacol (1996) 0.88
Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells. Mol Biol Cell (1999) 0.86
Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells. Biochem J (1997) 0.85
Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects. Br J Pharmacol (2001) 0.83
Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines. Biochem J (1997) 0.82
Potentiation of receptor-mediated cAMP production: role in the cross-talk between vasopressin V1a and V2 receptor transduction pathways. Biochem J (1998) 0.80
Sub-Nanomolar Sensitivity of Nitric Oxide Mediated Regulation of cGMP and Vasomotor Reactivity in Vascular Smooth Muscle. Front Pharmacol (2012) 0.78
Anti-spasmogenic activity of isoenzyme-selective phosphodiesterase inhibitors in guinea-pig trachealis. Br J Pharmacol (1999) 0.78
Receptor-mediated stimulation of lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE1B isoform of Ca2+/calmodulin-stimulated cAMP phosphodiesterase. Biochem J (1997) 0.78
The novel distribution of phosphodiesterase-4 subtypes within the rat retina. Neuroscience (2009) 0.77
Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors. Biochem J (1996) 0.77
Systems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General Case. PLoS Comput Biol (2016) 0.76
Phosphodiesterase 4 inhibitor rolipram potentiates the inhibitory effect of calcitonin on osteoclastogenesis. J Bone Miner Metab (2006) 0.76
Roflumilast and aquaporin-2 regulation in rat renal inner medullary collecting duct. Physiol Rep (2017) 0.75
Rapid Screening of Potential Phosphodiesterase Inhibitors from the Roots of Ilex pubescens Hook. et Arn. Using a Combination of Ultrafiltration and LC-MS. Evid Based Complement Alternat Med (2017) 0.75
Physiological and genetic regulation of the aldohexuronate transport system in Escherichia coli. J Bacteriol (1976) 1.60
The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells. Oncogene (2007) 1.47
Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3. Mol Pharmacol (1995) 1.42
[Metabolism of hexuronides and hexuronates in Escherichia coli K12: physiologic and genetic aspects of its regulation]. Biochimie (1974) 1.42
The ratPDE3/IVd phosphodiesterase gene codes for multiple proteins differentially activated by cAMP-dependent protein kinase. J Biol Chem (1994) 1.18
PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J Pathol (2008) 1.17
Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain. Mol Pharmacol (1998) 1.16
Role of c-kit in mammalian spermatogenesis. J Endocrinol Invest (2000) 1.11
A cell- and developmental stage-specific promoter drives the expression of a truncated c-kit protein during mouse spermatid elongation. Development (1996) 1.07
Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. Oncogene (2012) 1.05
Letter: Detection of e antigen by immunofluorescence in cytoplasm of hepatocytes of HBsAg carriers. Lancet (1976) 1.04
The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site. J Biol Chem (2000) 1.04
Structure of two rat genes coding for closely related rolipram-sensitive cAMP phosphodiesterases. Multiple mRNA variants originate from alternative splicing and multiple start sites. J Biol Chem (1994) 1.01
Selective inhibition of one of the cyclic AMP phosphodiesterases from rat brain by the neurotropic compound rolipram. Biochem Pharmacol (1985) 0.92
FLASH is essential during early embryogenesis and cooperates with p73 to regulate histone gene transcription. Oncogene (2011) 0.92
ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescence. Cell Death Differ (2013) 0.91
Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn. Mol Cell Biol (2009) 0.89
Identification of cyclic AMP-phosphodiesterase variants from the PDE4D gene expressed in human peripheral mononuclear cells. FEBS Lett (1996) 0.89
Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Mol Pharmacol (1993) 0.88
Mutations in the YRB1 gene encoding yeast ran-binding-protein-1 that impair nucleocytoplasmic transport and suppress yeast mating defects. Genetics (2001) 0.88
[Mutants for the hexuronate transport system in Escherichia coli K 12: physiological and genetic analysis]. C R Acad Sci Hebd Seances Acad Sci D (1974) 0.87
Selective activation of rolipram-sensitive, cAMP-specific phosphodiesterase isoforms by phosphatidic acid. Mol Pharmacol (1997) 0.87
Modulation of cellular responses by hormones: role of cAMP specific, rolipram-sensitive phosphodiesterases. Mol Cell Endocrinol (1994) 0.87
Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells. Mol Biol Cell (1999) 0.86
Comparison of cyclic nucleotide phosphodiesterase isoforms from rat heart and bovine aorta. Separation and inhibition by selective reference phosphodiesterase inhibitors. Biochem Pharmacol (1988) 0.86
Early increase in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells. J Cell Physiol (1992) 0.84
Selective stimulation of a cAMP-specific phosphodiesterase (PDE4A5) isoform by phosphatidic acid molecular species endogenously formed in rat thymocytes. Eur J Biochem (1997) 0.83
HIV-1 viral DNA is present in ejaculated abnormal spermatozoa of seropositive subjects. Hum Reprod (2007) 0.83
Markers of mechanical asphyxia: immunohistochemical study on autoptic lung tissues. Int J Legal Med (2013) 0.83
Chromosomal localization of the human and rat genes (PDE4D and PDE4B) encoding the cAMP-specific phosphodiesterases 3 and 4. Cytogenet Cell Genet (1995) 0.82
Use of ion chromatography for monitoring microbial spoilage in the fruit juice industry. J Chromatogr A (1997) 0.80
Monoclonal antibodies to native mouse angiotensin-converting enzyme (CD143): ACE expression quantification, lung endothelial cell targeting and gene delivery. Tissue Antigens (2006) 0.80
Activation of cyclic nucleotide phosphodiesterases in FRTL-5 thyroid cells expressing a constitutively active Gs alpha. Mol Endocrinol (1995) 0.79
Decreased cyclic nucleotide phosphodiesterase activity in human peripheral blood mononuclear cells from elderly women. Clin Sci (Lond) (1990) 0.79
Molecular mechanisms utilized by alternative c-kit gene products in the control of spermatogonial proliferation and sperm-mediated egg activation. Andrologia (2003) 0.79
Glial cell line-derived neurotrophic factor promotes invasive behaviour in testicular seminoma cells. Int J Androl (2012) 0.79
Elemental enteral nutrition preserves the mucosal barrier and improves the trophism of the villi after small bowel transplantation in piglets. Transplant Proc (2007) 0.79
One step purification of Escherichia coli beta-glucuronidase. Biochimie (1987) 0.79
Regulation of PDE-4 cAMP phosphodiesterases by phosphatidic acid. Cell Biochem Biophys (1998) 0.77
cAMP-dependent induction of PDE5 expression in murine neuroblastoma cell differentiation. FEBS Lett (1999) 0.77
Inhibition of heart and brain cyclic adenosine 3',5'-monophosphate phosphodiesterase by new non-steroidic compounds structurally related to natural cardenolides. Biochem Pharmacol (1978) 0.77
Regulation of cAMP-phosphodiesterases by phosphatidic acid binding. Lipids (1999) 0.77
Different fates of hepatitis B virus markers during plasma fractionation: a clue to the infectivity of blood derivatives. Vox Sang (1978) 0.77
Experimental small bowel transplantation from non-heart-beating donors: a large-animal study. Transplant Proc (2009) 0.76
Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some pentasubstituted quercetin analogs. Biochem Pharmacol (1982) 0.76
Effect of estrogen on adenosine 3'5',cyclic monophosphate in quail oviduct: possible involvement in estradiol-activated growth. Endocrinology (1988) 0.76
Glutathione peroxidase activity and metabolism of arachidonic acid in peripheral blood mononuclear cells from elderly subjects. Clin Sci (Lond) (1993) 0.76
In vitro and in vivo myocardial effects of a cyclic AMP phosphodiesterase inhibitor structurally related to natural cardenolides. Arch Int Pharmacodyn Ther (1979) 0.75
[On the antibacterial activity of 6-deoxy-oxy-tetracycline]. Antibiotica (1966) 0.75
Phosphatidic acid-dependent activation of adenosine-3',5'-cyclic-monophosphate-phosphodiesterase is necessary for Arg-vasopressin induction of myogenesis. Lipids (1999) 0.75
[Cyclic nucleotide phosphodiesterase in vertebrates]. Biochimie (1984) 0.75
Quantitative structure-activity relationships for the inhibition of heart and brain cyclic AMP phosphodiesterases by some phenylbutenolides. Biochem Pharmacol (1980) 0.75
Decreased adenosine cyclic 3',5'-monophosphate phosphodiesterase activity in rat brain following triethyltin intoxication. Biochem Pharmacol (1984) 0.75
Effects of an extract of Ginkgo biloba on the 3',5'-cyclic AMP phosphodiesterase activity of the brain of normal and triethyltin-intoxicated rats. J Neurochem (1987) 0.75
Cyclic nucleotide phosphodiesterase activity in the quail oviduct: hormonal regulation and involvement in estrogen-induced growth. Endocrinology (1988) 0.75
Prolonged survival with FK778 (malononitrilamide) monotherapy after small bowel transplantation: a large animal study. Transplant Proc (2007) 0.75
[Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors]. Ann Pharm Fr (1984) 0.75
Acetylcholinesterase distribution in subpopulations of murine thymocyte. J Neurosci Res (1991) 0.75